Addressing COPD and metabolic syndrome requires comprehensive research efforts

Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is needed to improve holistic patient care, according to a new editorial.

Quicktake – ImmunoGen Inc., (IMGN) | Biotech Investment Blog | biotickr

ImmunoGen Inc. is a clinical-stage biotechnology company focusing on the development of antibody-drug conjugate (ADC) as a treatment for cancer. The lead pipeline is mirvetuximab

June 9, 2023

CMN-005 by CoImmune for Nodal Marginal Zone B-Cell Lymphoma: Likelihood of Approval

CMN-005 is under clinical development by CoImmune and currently in Phase II for Nodal Marginal Zone B-Cell Lymphoma.

September 10, 2024

Sana lays off staff as cell therapy biotech awaits first clinical data

Cell therapy maker Sana Biotechnology is laying off staff, based on about half a dozen employee posts on LinkedIn in recent days, saying the company

September 1, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.